Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Existing prognostic tools for non-traumatic intracerebral hemorrhage (NCH) mainly focus on neurological injury severity but overlook systemic factors that cause secondary deterioration. This study aimed to evaluate the Advanced Lung Cancer Inflammation Index (ALI), a biomarker combining nutritional parameters (BMI, albumin) and inflammatory parameters (neutrophil-to-lymphocyte ratio, NLR), as a new prognostic indicator for NCH. It aimed to fill the gap in quantifying the synergy between inflammation and malnutrition in neurocritical care.In this retrospective cohort study, 1502 critically ill NCH patients from the MIMIC-IV database were analyzed. ALI was calculated as (BMI × Albumin)/NLR, and patients were divided into groups based on the quartiles of the log-transformed ALI. The outcomes measured were in-hospital, 90-day, and 1-year mortality. Multivariable logistic regression, ROC curve analysis, restricted cubic spline models, and subgroup analyses were used to assess the prognostic value of ALI.The results showed that lower ALI values could independently predict mortality at all time points. After comprehensive adjustment, a 1-unit increase in the log-transformed ALI was associated with a 26% reduction in in-hospital mortality (OR = 0.74, 95% CI: 0.64-0.86, P < 0.001). The fourth quartile (with the highest ALI) had 56% lower mortality compared to the first quartile (OR = 0.44, P = 0.001). ALI had a strong ability to distinguish in-hospital all-cause mortality (AUC = 0.853, 95% CI: 0.826-0.880, P < 0.001). A threshold effect was found (log-transformed ALI = 4.0), below which ALI was inversely related to mortality (P < 0.001), and above which the relationship leveled off. Subgroup analyses confirmed the consistency of these findings across different age groups, comorbidities, and organ dysfunctions (P for interaction > 0.05). In conclusion, ALI is a reliable prognosticator for NCH, reflecting the interaction between systemic inflammation and malnutrition. Its simplicity and potential for threshold-based stratification may help in personalized interventions. Further prospective validation of ALI-guided protocols is needed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041356PMC
http://dx.doi.org/10.1038/s41598-025-98854-8DOI Listing

Publication Analysis

Top Keywords

advanced lung
8
lung cancer
8
cancer inflammation
8
critically ill
8
log-transformed ali
8
ali
5
inflammation associated
4
mortality
4
associated mortality
4
mortality critically
4

Similar Publications

Identifying meaningful drug response biomarkers from public pharmacogenomic datasets with biologically informed interpretable neural networks.

Comput Biol Chem

September 2025

Faculty of Health Sciences, University of Macau, Avenida de Universidade, Taipa, Macao Special Administrative Region of China. Electronic address:

With the advancements of next-generation sequencing, publicly available pharmacogenomic datasets from cancer cell lines provide a handle for developing predictive models of drug responses and identifying associated biomarkers. However, many currently available predictive models are often just used as black boxes, lacking meaningful biological interpretations. In this study, we made use of open-source drug response data from cancer cell lines, in conjunction with KEGG pathway information, to develop sparse neural networks, K-net, enabling the prediction of drug response in EGFR signaling pathways and the identification of key biomarkers.

View Article and Find Full Text PDF

Background: Cystic fibrosis (CF) is a genetic disorder that remains underrecognized across Africa, where limited diagnostic capacity, low awareness, and competing health priorities contribute to delayed or missed diagnoses [1-4]. Although increasing data suggests CF is more prevalent than previously believed in Africa, survival remains poor [1]. These challenges do not only affect people with CF (pwCF) in Africa but also have implications for global understanding of the disease, particularly among populations historically excluded from CF research and treatment advances.

View Article and Find Full Text PDF

Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy.

J Allergy Clin Immunol

September 2025

National Heart and Lung Institute, Imperial College London, London, United Kingdom; Frankland and Kay Allergy Centre, UK NIHR Imperial Biomedical Research Centre, United Kingdom.

Recent advancements in genomics and "omic" technologies have ushered in a transformative era referred to as personalized or precision medicine. This innovative approach considers the unique genetic profiles of individuals, along with a range of variability factors, to devise tailored disease treatments and prevention strategies that cater to the distinct needs of each patient. Although the terms personalized medicine and precision medicine are frequently utilized interchangeably, it is essential to delineate the subtle distinctions between them.

View Article and Find Full Text PDF

Background: Acute heart failure with reduced ejection fraction (AHF) remains a leading cause of ED visits, hospitalizations, and in-hospital mortality.

Objectives: To evaluate the prognostic utility of the Scottish Inflammatory Prognostic Score (SIPS) in patients with AHF.

Methods: This retrospective study analyzed 508 patients admitted with AHF between November 2022 and November 2024.

View Article and Find Full Text PDF

Evodiamine attenuates silica-induced pulmonary fibrosis via PI3K/AKT pathway suppression: Integrated computational and experimental validation.

Biochem Biophys Res Commun

September 2025

Guangdong Province Hospital for Occupational Diseases Prevention and Treatment, Guangzhou, China; School of Public Health, Southern Medical University, Guangzhou, China. Electronic address:

Background: Silicosis, a devastating occupational lung disease caused by silica dust inhalation, lacks effective treatment options. Evodiamine (Evo), a bioactive alkaloid, has demonstrated anti-fibrotic potential in various diseases; however, its efficacy in silicosis and underlying mechanisms remain elusive. This study aims to systematically investigate Evo's therapeutic effects and mechanisms against silicosis.

View Article and Find Full Text PDF